Cian Healthcare Limited (BOM:542678)
36.23
+0.71 (2.00%)
At close: Nov 6, 2026
Cian Healthcare Revenue
In the fiscal year ending March 31, 2026, Cian Healthcare had annual revenue of 282.99M INR, down -8.28%. Cian Healthcare had revenue of 169.77M in the half year ending March 31, 2026, a decrease of -42.02%. That makes Cian Healthcare the 41,462nd largest company in the world by revenue and 4,133rd in India.
Revenue
282.99M
Revenue Growth
-8.28%
P/S Ratio
3.20
Revenue / Employee
1.66M
Employees
170
Market Cap
905.75M
Revenue by Geography
- India 175.53M 62.0%
- Export 107.46M 38.0%
Fiscal year ended Mar 31, 2026 See the full Cian Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 282.99M | -25.55M | -8.28% |
| Mar 31, 2025 | 308.54M | -310.38M | -50.15% |
| Mar 31, 2024 | 618.92M | -67.84M | -9.88% |
| Mar 31, 2023 | 686.76M | -93.90M | -12.03% |
| Mar 31, 2022 | 780.66M | 41.25M | 5.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Concord Drugs | 860.69M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Speciality Medicines | 752.85M |
| Mercury Laboratories | 737.65M |
| Shelter Pharma | 731.34M |
| Onyx Biotec | 694.69M |
| Amwill Health Care | 469.16M |